Thyroid Eye Disease (TED)

Explore clinical trials studying Thyroid Eye Disease (TED). Study availability and eligibility vary by location and protocol.

9 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Thyroid Eye Disease (TED) trial results

Recruiting

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

NCT07404111

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Kriya Clinical Trial Site Livonia, Michigan, United States

Kriya Clinical Trial Site Las Vegas, Nevada, United States

Kriya Clinical Trial Site Erie, Pennsylvania, United States

Kriya Clinical Trial Site Auckland, New Zealand

View Trial Details

Recruiting

MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

NCT07257185

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

NCT07262476

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

NCT06569758

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +15 more
Locations: Shanghai Ninth People's hospital, Shanghai Jiaotong University School of Medication Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

NCT07211776

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Site01006 Beijing, China

Site01009 Beijing, China

Site01010 Beijing, China

Site01029 Bengbu, China

View all 27 locations

View Trial Details

Not yet recruiting

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

NCT07620405

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Prospective Observational Study of Smartphone-Based AI Self-Monitoring During Non-Surgical Treatment for Thyroid Eye Disease (THYROSCOPE)

NCT07623993

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: 3003 North First Street #221 San Jose, California, United States

View Trial Details

Not yet recruiting

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

NCT07308964

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +14 more
Locations: Not specified

View Trial Details

Active, not recruiting

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT06812325

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Catalina Eye Care Tuscon, Arizona, United States

United Medical Research Institute Inglewood, California, United States

Orbital Plastics Newport Beach, California, United States

California Eye Specialists Medical Group INC Pasadena, California, United States

View all 64 locations

View Trial Details

Thyroid Eye Disease (TED)

Thyroid Eye Disease (TED) trial results

Related conditions